AIM

#5056
AIM ImmunoTech Inc.
0.5457 USD
-5.91%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
0.5240
0.5457
Intervallo Annuale
0.5060
20.3500
Variazione giornaliera
-5.91%
Variazione Mensile
-27.24%
Variazione di 6 mesi
-79.72%
Variazione Annuale
-93.58%
Chiusura Precedente
0.5800
Apertura
0.5241
Bid
Ask
Minimo
0.5240
High
0.5457
Volume
156
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 4.4462 M
  • Employee 21
  • Founded N/A
  • CEO N/A
  • Website www.aimimmuno.com
  • Headquarter Delaware, United States
  • FIGI BBG000JL6Z80
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.13
Rapporto prezzo/fatturato
20.76

AIM ImmunoTech Inc

AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees. The company has created an immunomodulatory double stranded RNA drug called Ampligen. It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome.

Notizie